A few days ago I wrote a post about generic painkillers and the fact that doctors themselves—who should know better—often don't use them. "If physicians aren't really sold on generics in their own personal lives," I asked, "does this mean they're not really sold on them in their professional lives too?" Well, perhaps I got it backwards. A friend sent me a link to a Forbes article from last year about the FDA retracting its approval of a generic version of Wellbutrin: The episode is bringing momentum to a movement that has been quietly building among many doctors and medical societies that are increasingly willing to ask a question that borders on heresy: Are generics really identical to the branded products they are meant to replicate? To a surprising degree, they say, the answer is no. |
Copyright
(c) 2010-2024 Jon L Gelman, All Rights Reserved.
Showing posts with label Forbes. Show all posts
Showing posts with label Forbes. Show all posts
Tuesday, July 29, 2014
Take Two: Just How Good Are Generic Meds Anyway?
Subscribe to:
Posts (Atom)